Captrust Financial Advisors Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Captrust Financial Advisors cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,123 shares of the medical equipment provider’s stock after selling 14,215 shares during the period. Captrust Financial Advisors’ holdings in Intuitive Surgical were worth $12,834,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the third quarter worth $558,807,000. International Assets Investment Management LLC grew its stake in Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC increased its holdings in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Strategic Financial Concepts LLC raised its position in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Finally, Manning & Napier Advisors LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at about $91,466,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 238 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total value of $113,645.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,629,115. This represents a 4.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 50,459 shares of company stock valued at $26,080,251. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $542.00 on Monday. The company has a market cap of $193.05 billion, a price-to-earnings ratio of 87.14, a price-to-earnings-growth ratio of 5.33 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The stock’s 50-day moving average is $510.03 and its 200-day moving average is $469.49.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Truist Financial upped their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. Finally, Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.